Randomized Controlled Trial of Large Language Model-Assisted Diagnostic Accuracy in Nephrology.
Rigorous testing shows AI-assisted diagnosis improves physician accuracy in kidney disease, suggesting AI can meaningfully enhance clinical decision-making.
This randomized controlled trial is the first to rigorously test LLM-assisted diagnostic accuracy against standard care in a clinical nephrology setting, using a true experimental design. The findings provide direct human-outcome evidence that AI assistance improves physician decision-making, with broad implications for clinical AI deployment across medical specialties.
What the study was
- Study design
- Randomized controlled trial
- Population
- Nephrologists evaluating clinical cases with or without LLM assistance
- Category
- Diagnostics
- Maturity
- Potentially Practice-Changing
- Journal
- Kidney international reports
Why it surfaced
First RCT of LLM-assisted clinical diagnosis. RCT design is the gold standard for evaluating clinical AI tools. Nephrology results are directly generalizable to other subspecialties. PMC full text available.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.